Compare AbCellera Biologics Inc (ABCL) vs Autodesk Inc (ADSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Autodesk Inc — how do they compare? AbCellera Biologics Inc trades at $9.06 (market cap $2.99B), while Autodesk Inc trades at $249.61 (market cap $53.12B). The key difference: Autodesk Inc is far larger — about 17.8× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Autodesk Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | ADSK | |
|---|---|---|
Market Cap | $2.99B | $53.12B |
Sector | Health | Technology |
52-Week High | $9.76 | $326.79 |
52-Week Low | $2.78 | $187.72 |
Enterprise Value | $2.58B | $52.92B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Autodesk Inc
Founded in 1982, Autodesk is an application software company that serves industries in architecture, engineering, and construction.
Read more on ADSK →
